Intravenous vs Oral Analgesia in Cancer Patients With Severe Pain After Successful Titration

PHASE2CompletedINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

April 10, 2020

Primary Completion Date

October 21, 2020

Study Completion Date

November 21, 2020

Conditions
Cancer Pain
Interventions
DRUG

PCA IV Hydromorphone (continuous dose = 0)

Intravenous PCA with hydromorphone after successful titration of 24 hours. the PCA setting: 1) continuous dose = 0; 2) bolus dose = 10-20% of the total dosage of hydromorphone in the previous 24 hours: 3) lockout time = 10 minutes; 4) evaluate once every 24 hours

DRUG

PCA IV Hydromorphone (continuous dose ≠ 0)

Intravenous PCA with hydromorphone after successful titration of 24 hours. the PCA setting: 1) continuous dose (dose/hours) = the total dosage of hydromorphone in the previous 24 hours/24; 2) bolus dose = 10-20% of the total dosage of hydromorphone in the previous 24 hours; 3) lockout time = 10 minutes; 4) evaluate once every 24 hours

DRUG

Oral morphine

"Swift to sustained-release morphine orally as background dose with immediate release morphine orally for breakthrough pain after successful titration of 24 hours.~Administration of morphine orally 1) Sustained-release morphine orally (dose/12 hours) = the total equianalgesic of the previous 24 hours/2×75% for d1; the total equianalgesic of the previous 24 hours/2 for day 2 and day 3; 2) Immediate release morphine orally = 10-20% of the total equianalgesic of the previous 24 hours; 3) Evaluate once every 24 hours"

Trial Locations (1)

350014

China, Fujian, Fuzhou

All Listed Sponsors
lead

Fujian Cancer Hospital

OTHER_GOV

NCT04243954 - Intravenous vs Oral Analgesia in Cancer Patients With Severe Pain After Successful Titration | Biotech Hunter | Biotech Hunter